PLK2 and PLK3 have been proposed to act as tumor suppressor proteins [86,113], and the loss of PLK2 was identified as a common change found in colorectal carcinomas, lending support to PLK2 being identified as a tumor suppressor [114]. Here, PLK3 is linked to neoplasm.